Back to Agenda
Session 3 - Challenges for Industrialization and Launch Phase
Session Chair(s)
Keiji Miyamoto
Principal Post-Marketing Regulatory Affairs Dep.
Daiichi Sankyo Co.,Ltd., Japan
Speaker(s)
Issues Recognized through the Development of Epithelial Cell Sheet for Esophageal Regeneration (CLS2702C/D)
Setsuko Hashimoto, PhD
CellSeed Inc., Japan
President and CEO
Post-Marketing Activities for Autologous Cultured Epidermis and Cartilage
Kenichiro Hata, MD, PhD
Japan Tissue Engineering Co., Ltd., Japan
President and CEO,
Current Situation and Operational Issues for National Regenerative Medicine Database
Kiyoshi Okada, MD, PhD
Osaka University Hospital, Japan
Vice Director, Medical Ctr for Translational Research,Dept of Medical Innovation
Have an account?